Search Results - "Hofer, Benedikt"
-
1
Letter: Zinc and Selenium—Potential Biomarkers for Chronic Liver Disease? Authors' Reply
Published in Alimentary pharmacology & therapeutics (01-11-2024)“…LINKED CONTENT This article is linked to Dominik et al papers. To view these articles, visit https://doi.org/10.1111/apt.18179 and…”
Get full text
Journal Article -
2
Decreased platelet activation predicts hepatic decompensation and mortality in patients with cirrhosis
Published in Hepatology (Baltimore, Md.) (01-11-2024)“…Patients with cirrhosis show alterations in primary hemostasis, yet prognostic implications of changes in platelet activation remain controversial, and assay…”
Get full text
Journal Article -
3
Editorial: ARFI‐based techniques are better than VCTE for diagnosing advanced fibrosis in severe obesity—Authors' reply
Published in Alimentary pharmacology & therapeutics (01-07-2024)“…LINKED CONTENT This article is linked to Vuijk et al papers. To view these articles, visit https://doi.org/10.1111/apt.18019 and…”
Get full text
Journal Article -
4
Prevalence and prognostic value of zinc and selenium deficiency in advanced chronic liver disease
Published in Alimentary pharmacology & therapeutics (01-10-2024)“…Summary Background and Aims Zinc and selenium are essential trace elements involved in important (patho)physiological processes. The prevalence and prognostic…”
Get full text
Journal Article -
5
Letter: The Prognostic Role of IGF ‐1 in Chronic Liver Disease—Authors' Reply
Published in Alimentary pharmacology & therapeutics (03-11-2024)Get full text
Journal Article -
6
Prognostic impact of sarcopenia in cirrhotic patients stratified by different severity of portal hypertension
Published in Liver international (01-04-2021)“…Background and Aims Portal hypertension (PH) and sarcopenia are common in patients with advanced chronic liver disease (ACLD). However, the interaction between…”
Get full text
Journal Article -
7
Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver disease
Published in Alimentary pharmacology & therapeutics (01-06-2024)“…Summary Background and Aims The prognostic performance of von Willebrand factor (VWF) may vary across clinical stages of advanced chronic liver disease (ACLD)…”
Get full text
Journal Article -
8
The deep abdominal ultrasound transducer (DAX) increases the success rate and diagnostic accuracy of shear wave elastography for liver fibrosis assessment in patients with obesity—A prospective biopsy‐controlled study
Published in Alimentary pharmacology & therapeutics (01-07-2024)“…Summary Background Obesity impacts the diagnostic accuracy of shear wave elastography (SWE). A deep abdominal ultrasound transducer (DAX) capable of point…”
Get full text
Journal Article -
9
Reflex testing for anti-HDV in HBsAg-positive patients offers high diagnostic yield in a large Central European tertiary care center
Published in Scientific reports (29-10-2024)“…Current guidelines recommend reflex testing for hepatitis D virus (HDV) coinfection in hepatitis B surface antigen (HBsAg)-positive patients over risk-factor…”
Get full text
Journal Article -
10
Assessment of portal hypertension severity using machine learning models in patients with compensated cirrhosis
Published in Journal of hepatology (01-02-2023)“…In individuals with compensated advanced chronic liver disease (cACLD), the severity of portal hypertension (PH) determines the risk of decompensation…”
Get full text
Journal Article -
11
High histamine levels are associated with acute-on-chronic liver failure and liver-related death in patients with advanced chronic liver disease
Published in Liver international (01-11-2024)“…The role of histamine in advanced chronic liver disease (ACLD) is poorly understood. We investigated plasma histamine levels across ACLD stages and their…”
Get full text
Journal Article -
12
Coregulation Analysis of Mechanistic Biomarkers in Autosomal Dominant Polycystic Kidney Disease
Published in International journal of molecular sciences (26-06-2021)“…Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disorder leading to deterioration of kidney function and end stage…”
Get full text
Journal Article -
13
FXR-FGF19 signaling in the gut–liver axis is dysregulated in patients with cirrhosis and correlates with impaired intestinal defence
Published in Hepatology international (01-06-2024)“…Background and aims Experimental studies linked dysfunctional Farnesoid X receptor (FXR)-fibroblast growth factor 19 (FGF19) signaling to liver disease. This…”
Get full text
Journal Article -
14
Letter: Fibrates may be safe and effective in patients with primary biliary cholangitis and decompensated cirrhosis—Authors' reply
Published in Alimentary pharmacology & therapeutics (01-07-2024)“…LINKED CONTENT This article is linked to Hofer et al papers. To view these articles, visit https://doi.org/10.1111/apt.17908 and…”
Get full text
Journal Article -
15
Editorial: Recompensation in PBC is good. But is it good enough? Authors' reply
Published in Alimentary pharmacology & therapeutics (01-05-2024)“…LINKED CONTENT This article is linked to Hofer et al papers. To view these articles, visit https://doi.org/10.1111/apt.17908 and…”
Get full text
Journal Article -
16
Acute hemodynamic response to propranolol predicts bleeding and nonbleeding decompensation in patients with cirrhosis
Published in Hepatology communications (01-09-2022)“…Nonselective beta‐blockers are used as prophylaxis for variceal bleeding in patients with advanced chronic liver disease (ACLD). The acute hemodynamic response…”
Get full text
Journal Article -
17
Transcriptomic signatures of progressive and regressive liver fibrosis and portal hypertension
Published in iScience (15-03-2024)“…Persistent liver injury triggers a fibrogenic program that causes pathologic remodeling of the hepatic microenvironment (i.e., liver fibrosis) and portal…”
Get full text
Journal Article -
18
Evaluation of potential hepatic recompensation criteria in patients with PBC and decompensated cirrhosis
Published in Alimentary pharmacology & therapeutics (01-04-2024)“…Summary Background Aetiological therapy improves liver function and may enable hepatic recompensation in decompensated cirrhosis. Aims We explored the…”
Get full text
Journal Article -
19
Distinct structural and dynamic components of portal hypertension in different animal models and human liver disease etiologies
Published in Hepatology (Baltimore, Md.) (01-03-2022)“…Background and Aims Liver fibrosis is the static and main (70%‐80%) component of portal hypertension (PH). We investigated dynamic components of PH by a…”
Get full text
Journal Article -
20
Deviations From the Ideal Plasma Volume and Isolated Tricuspid Valve Surgery-Paving the Way for New Risk Stratification Parameters
Published in Frontiers in cardiovascular medicine (25-03-2022)“…Congestion and plasma volume expansion are important features of heart failure, whose prognostic significance has been investigated in a range of surgical and…”
Get full text
Journal Article